Last reviewed · How we verify
NCT05259995
Sustained Acoustic Medicine Ultrasound Diathermy Clinical Performance
Phase 1 trial testing Sustained Acoustic Medicine in Measurement of Diathermy on Anatomical Locations of the Body in 54 participants. Completed in 30 June 2022.
30 June 2022
Quick facts
| Lead sponsor | ZetrOZ, Inc. |
|---|---|
| Phase | Phase 1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 54 |
| Start date | 21 February 2022 |
| Primary completion | 30 June 2022 |
| Estimated completion | 30 June 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Sustained Acoustic Medicine
Conditions studied
- Measurement of Diathermy on Anatomical Locations of the Body — all drugs for Measurement of Diathermy on Anatomical Locations of the Body →
Sponsor
ZetrOZ, Inc. — full company profile →
Who can join
Adults 18 to 70, any sex, with Measurement of Diathermy on Anatomical Locations of the Body. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to measure diathermy performance of Sustained Acoustic Medicine Devices with commercially available ultrasound gel coupling patches.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Clinical Diathermy Performance Evaluation of Multi-hour Sustained Acoustic Medicine Treatment with 2.5% Diclofenac Ultrasound Coupling Patch.
Hendren TF, Yeretzian NR, Bavanasi K. · · 2023 · cited 2× · PMID 37692795
Verify or expand the search:
- PubMed search for NCT05259995
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Sustained Acoustic Medicine
Trials testing the same drug.
- NCT06510062 — Comparative Evaluation of Sustained Acoustic Medicine Device on Circulation · Phase 1 · completed
Other ZetrOZ, Inc. trials
Trials by the same sponsor.
- NCT07515872 — Long Duration High Frequency Ultrasound for the Treatment of Osteoarthritis · Phase 2 · not yet recruiting
- NCT06257537 — Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to Osteoarthritis · Phase 2 · recruiting
- NCT06510062 — Comparative Evaluation of Sustained Acoustic Medicine Device on Circulation · Phase 1 · completed
- NCT05882812 — Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Knee Pain Related to Osteoarthritis · Phase 2 · completed
- NCT05883241 — Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Pain Related to Bone Fracture · Phase 1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05259995 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by ZetrOZ, Inc.
- Last refreshed: 21 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05259995.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing